87 related articles for article (PubMed ID: 34331592)
1. Correction to: SHARPIN overexpression induces tumorigenesis in human prostate cancer LNCaP, DU145 and PC-3 cells via NF-κB/ERK/Akt signaling pathway.
Li J; Lai Y; Cao Y; Du T; Zeng L; Wang G; Chen X; Chen J; Yu Y; Zhang S; Zhang Y; Huang H; Guo Z
Med Oncol; 2021 Jul; 38(9):104. PubMed ID: 34331592
[No Abstract] [Full Text] [Related]
2. SHARPIN overexpression induces tumorigenesis in human prostate cancer LNCaP, DU145 and PC-3 cells via NF-κB/ERK/Akt signaling pathway.
Li J; Lai Y; Cao Y; Du T; Zeng L; Wang G; Chen X; Chen J; Yu Y; Zhang S; Zhang Y; Huang H; Guo Z
Med Oncol; 2015 Feb; 32(2):444. PubMed ID: 25550157
[TBL] [Abstract][Full Text] [Related]
3. Elevation of SHARPIN Protein Levels in Prostate Adenocarcinomas Promotes Metastasis and Impairs Patient Survivals.
Huang H; Du T; Zhang Y; Lai Y; Li K; Fan X; Zhu D; Lin T; Xu K; Huang J; Liu L; Guo Z
Prostate; 2017 May; 77(7):718-728. PubMed ID: 28230260
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of the novel quinazolinone MJ-33: inhibition of metastasis through the MAPK, AKT, NF-κB and AP-1 signaling pathways in DU145 human prostate cancer cells.
Hour MJ; Tsai SC; Wu HC; Lin MW; Chung JG; Wu JB; Chiang JH; Tsuzuki M; Yang JS
Int J Oncol; 2012 Oct; 41(4):1513-9. PubMed ID: 22825655
[TBL] [Abstract][Full Text] [Related]
5. SH003 induces apoptosis of DU145 prostate cancer cells by inhibiting ERK-involved pathway.
Choi YJ; Choi YK; Lee KM; Cho SG; Kang SY; Ko SG
BMC Complement Altern Med; 2016 Dec; 16(1):507. PubMed ID: 27927199
[TBL] [Abstract][Full Text] [Related]
6. [NF-κB subunits regulate maspin expression in prostate cancer cells in vitro].
Ma L; Shen YY; Zhou P; Zhou J; Guo F
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):165-8. PubMed ID: 22780967
[TBL] [Abstract][Full Text] [Related]
7. Potential mechanism for the effects of dexamethasone on growth of androgen-independent prostate cancer.
Nishimura K; Nonomura N; Satoh E; Harada Y; Nakayama M; Tokizane T; Fukui T; Ono Y; Inoue H; Shin M; Tsujimoto Y; Takayama H; Aozasa K; Okuyama A
J Natl Cancer Inst; 2001 Nov; 93(22):1739-46. PubMed ID: 11717335
[TBL] [Abstract][Full Text] [Related]
8. Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway.
Deeb D; Jiang H; Gao X; Al-Holou S; Danyluk AL; Dulchavsky SA; Gautam SC
J Pharmacol Exp Ther; 2007 May; 321(2):616-25. PubMed ID: 17289836
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway.
Wang X; Klein RD
Mol Carcinog; 2007 Nov; 46(11):912-23. PubMed ID: 17427962
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation.
Kukreja P; Abdel-Mageed AB; Mondal D; Liu K; Agrawal KC
Cancer Res; 2005 Nov; 65(21):9891-8. PubMed ID: 16267013
[TBL] [Abstract][Full Text] [Related]
11. IQGAP2, A candidate tumour suppressor of prostate tumorigenesis.
Xie Y; Yan J; Cutz JC; Rybak AP; He L; Wei F; Kapoor A; Schmidt VA; Tao L; Tang D
Biochim Biophys Acta; 2012 Jun; 1822(6):875-84. PubMed ID: 22406297
[TBL] [Abstract][Full Text] [Related]
12. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells.
Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N
Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-23b-3p promotes pancreatic cancer cell tumorigenesis and metastasis via the JAK/PI3K and Akt/NF-κB signaling pathways.
Zhang Y; Chen D; Zhang G; Wu X; Zhou L; Lin Y; Ding J; An F; Zhan Q
Oncol Lett; 2020 Nov; 20(5):160. PubMed ID: 32934728
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of EGR-1 modulates the activity of NF-κB and AP-1 in prostate carcinoma PC-3 and LNCaP cell lines.
Parra E; Ferreira J; Ortega A
Int J Oncol; 2011 Aug; 39(2):345-52. PubMed ID: 21617851
[TBL] [Abstract][Full Text] [Related]
15. Carnosic acid modulates Akt/IKK/NF-κB signaling by PP2A and induces intrinsic and extrinsic pathway mediated apoptosis in human prostate carcinoma PC-3 cells.
Kar S; Palit S; Ball WB; Das PK
Apoptosis; 2012 Jul; 17(7):735-47. PubMed ID: 22453599
[TBL] [Abstract][Full Text] [Related]
16. Acacetin (5,7-dihydroxy-4'-methoxyflavone) exhibits in vitro and in vivo anticancer activity through the suppression of NF-κB/Akt signaling in prostate cancer cells.
Kim HR; Park CG; Jung JY
Int J Mol Med; 2014 Feb; 33(2):317-24. PubMed ID: 24285354
[TBL] [Abstract][Full Text] [Related]
17. Signal transduction responses to lysophosphatidic acid and sphingosine 1-phosphate in human prostate cancer cells.
Gibbs TC; Rubio MV; Zhang Z; Xie Y; Kipp KR; Meier KE
Prostate; 2009 Oct; 69(14):1493-506. PubMed ID: 19536794
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway.
Li Y; Sarkar FH
Clin Cancer Res; 2002 Jul; 8(7):2369-77. PubMed ID: 12114442
[TBL] [Abstract][Full Text] [Related]
19. PI3K/Akt-dependent transcriptional regulation and activation of BMP-2-Smad signaling by NF-kappaB in metastatic prostate cancer cells.
Graham TR; Odero-Marah VA; Chung LW; Agrawal KC; Davis R; Abdel-Mageed AB
Prostate; 2009 Feb; 69(2):168-80. PubMed ID: 18942118
[TBL] [Abstract][Full Text] [Related]
20. Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer.
Chen X; Thakkar H; Tyan F; Gim S; Robinson H; Lee C; Pandey SK; Nwokorie C; Onwudiwe N; Srivastava RK
Oncogene; 2001 Sep; 20(42):6073-83. PubMed ID: 11593415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
